DNA and RNA from pathogens

Nucleic acids from pathogens

Pathogen nucleic acid extraction from clinical samples

The importance of sensitive pathogen detection from clinical samples cannot be understated. The ability to verify the presence of these microorganisms at low concentrations is important to properly detect persons who are both symptomatic and asymptomatic.  The PerkinElmer chemagen technology has been developed to isolate pathogen DNA and RNA including viruses, bacteria, fungi, and other microorganisms.  The chemagic™ instruments not only provide highly sensitive extractions, but they are also developed for high-throughput laboratory automation.  The PerkinElmer chemagic™ pathogen kits can extract a wide range of pathogens, including respiratory samples1-3 (e.g. COVID-19), blood-derived samples4,5, enteric samples6,7, and well as a host of other body fluids and tissues8,9.  The nucleic acids purified using the PerkinElmer chemagen workflows are suitable for a wide range of downstream applications, such as Next Generation Sequencing (NGS), quantitative and digital PCR, hybridization, and many more.

Workflow for pathogen detection, on the basis of SARS-CoV-2 detection

Workflow for pathogen detection, using SARS-CoV-2 detection as an example

For research use only. Not for use in diagnostic procedures.